Anthropic's AI makes breakthrough in enzyme discovery

Anthropic has claimed its AI, Claude, has autonomously discovered a new enzyme system, likening it to the machinery behind the gene-editing tool CRISPR. This marks the first result from the company's newly launched wet lab and serves as an early test of Claude's scientific capabilities as Anthropic prepares for its public offering. The discovery was made after nearly 950 Claude agents processed 210 million tokens over 21 hours, identifying an unusual repeating pattern in a massive DNA sequence database. The company emphasized that its scientists were only involved in the initial prompt and lab work, highlighting the AI's role in the process. The breakthrough underscores Anthropic's commitment to integrating AI into scientific research, showcasing its potential to revolutionize biotechnology and genetic engineering. The findings represent a significant step forward in the application of AI to biological research, with implications for future advancements in gene editing and molecular biology. Anthropic's approach demonstrates how AI can be leveraged to analyze complex biological data, potentially accelerating discoveries that would traditionally take years of manual research. This development could pave the way for new innovations in biotechnology, driven by the synergy between artificial intelligence and experimental science.